Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| SARC | rs3813114 | chr18:71815122 | G/A | 2.24E-5 | 258 | 31.98 | 31.97 | 6.43 | KM Plot |
| SARC | rs3813115 | chr18:71815063 | A/G | 9.97E-6 | 258 | 6.43 | 28.28 | 32.4 | KM Plot |
| SARC | rs3814734 | chr11:71192851 | A/G | 2.68E-5 | 255 | 8.62 | 20.4 | 33.2 | KM Plot |
| SARC | rs3826536 | chr17:45501967 | T/A | 6.35E-5 | 256 | 19.97 | 33.6 | 32.3 | KM Plot |
| SARC | rs3831063 | chr11:34979276 | GT/G | 9.56E-5 | 248 | 20.17 | 29.62 | 33.48 | KM Plot |
| SARC | rs3838794 | chr11:71202489 | T/TAGTC | 2.54E-5 | 254 | 8.62 | 25.65 | 33.48 | KM Plot |
| SARC | rs3851808 | chr17:45425144 | C/T | 2.72E-5 | 253 | 19.97 | 34 | 31.97 | KM Plot |
| SARC | rs3857171 | chr4:7005753 | C/T | 1.74E-5 | 252 | 16.17 | 33.2 | 32.3 | KM Plot |
| SARC | rs4060889 | chr17:45427301 | T/C | 2.67E-5 | 248 | 19.97 | 34 | 31.77 | KM Plot |
| SARC | rs4114873 | chr17:45495270 | G/A | 8.85E-5 | 258 | 19.97 | 34 | 32.35 | KM Plot |
| SARC | rs41382557 | chr13:42895839 | C/T | 0 | 258 | 1.07 | 28.33 | 32.13 | KM Plot |
| SARC | rs41464149 | chr13:89443490 | A/G | 0 | 258 | 2.35 | 30.93 | 32.3 | KM Plot |
| SARC | rs4266409 | chr5:28489325 | C/T | 3.33E-16 | 258 | 32.13 | 33.2 | 3.1 | KM Plot |
| SARC | rs4274691 | chr3:38867396 | G/A | 3.92E-5 | 247 | 31.93 | 35.57 | 14.82 | KM Plot |
| SARC | rs4289298 | chr3:38945180 | G/A | 3.47E-7 | 254 | 13.47 | 36.53 | 29.62 | KM Plot |